staceywhite, Author at European Medical Journal - Page 4 of 195

Retraction: Talokinumab in Moderate-to-Severe Atopic Dermatitis: The Latest Data

The latest issue of EMJ Innovations

Expert Tone on Post-Stroke Spasticity

Tune into this episode discussing the management of post-stroke spasticity to improve patient outcomes by recognising, diagnosing, and…

GIANT 2025 Interview: Tom Coffey OBE

Tom Coffey OBE. Senior Health Adviser to the Mayor of London, UK. At this year’s Global Innovation and New Technology (GIANT) Health event…

GIANT 2025 Interview: Roy Lilley

GIANT 2025 Interview: Roy Lilley. Founder and Editor-in-Chief, nhsManagers.net; Founder, The Academy of Fabulous NHS Stuff, London, UK…..

22 Dec 2025

Navigating Head and Neck Atopic Dermatitis

This ICS highlights key symptoms, diagnostic features, and evolving treatment approaches, including the use of tralokinumab…

19 Dec 2025

Interactive Case Study: Asthma with Persistent Airway Obstruction

This case describes hypothetical patient scenarios. Outcomes presented may not reflect clinical study results or real-world practice…

Targeting the First-Line in HER2-Mutant NSCLC

Treatment for advanced non-small cell lung cancer (NSCLC) with activating mutations in HER2 relies on chemo-immunotherapy in the…

Evolving Epilepsy Landscape

During this symposium, leading international epileptologists discussed the key challenges and opportunities that currently exist within…

Disease Burden in Treated SMA

Spinal muscular atrophy (SMA) is a neuromuscular disorder characterized by loss of motor neurons in the spinal cord and brain stem…